{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:32Z","timestamp":1754153432534,"version":"3.41.2"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clindermatol.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:27:37Z","timestamp":1747337257000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hidradenitis suppurativa in children and adolescents"],"prefix":"10.1016","volume":"43","author":[{"given":"Nives","family":"Pustisek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana Ozanic","family":"Bulic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnes","family":"Resic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Bulic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2025.05.005_bib0001","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian hidradenitis suppurativa foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2020.09.072","article-title":"Quality of life in hidradenitis suppurativa: a cross-sectional study of a pediatric population","volume":"84","author":"McAndrew","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.clindermatol.2025.05.005_bib0003","doi-asserted-by":"crossref","DOI":"10.5070\/D32612051346","article-title":"Recent advances in hidradenitis suppurativa in pediatrics","volume":"26","author":"Rundle","year":"2020","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0004","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jid.2018.04.001","article-title":"Prevalence estimates for Hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0005","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/jdv.16520","article-title":"Hidradenitis suppurativa in paediatric patients: a retrospective monocentric study in Germany and review of the literature","volume":"34","author":"Vaiopoulos","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0006","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","article-title":"Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients","volume":"157","author":"Liy-Wong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0008","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/pde.13466","article-title":"Hidradenitis suppurativa in children: the Henry Ford experience","volume":"35","author":"Braunberger","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0009","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2015.07.051","article-title":"Hidradenitis suppurativa in the pediatric population","volume":"73","author":"Liy-Wong","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/ijd.14639","article-title":"Hidradenitis suppurativa in a cohort of overweight and obese children and adolescents","volume":"59","author":"Linds\u00f8 Andersen","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000481836","article-title":"Hidradenitis suppurativa: an Asian perspective from a Singaporean institute","volume":"4","author":"Choi","year":"2018","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jdv.15827","article-title":"Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines","volume":"33","author":"Offidani","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0014","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/pde.12271","article-title":"Skin disorders associated with obesity in children and adolescents: a population-based study","volume":"31","author":"Mirmirani","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/jpem-2011-0277","article-title":"Association of early menarche age and overweight\/obesity","volume":"25","author":"Brali\u0107","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0016","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2230.2001.00876.x","article-title":"Early-onset hidradenitis suppurativa","volume":"26","author":"Palmer","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2133.1993.tb03174.x","article-title":"Hidradenitis suppurativa as a presenting feature of premature adrenarche","volume":"129","author":"Lewis","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0018","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamadermatol.2020.1047","article-title":"Association of birth weight, childhood body mass index, and height with risk of hidradenitis suppurativa","volume":"156","author":"J\u00f8rgensen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa","volume":"198","author":"K\u00f6nig","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2017.04.006","article-title":"A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa","volume":"87","author":"Dessinioti","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0021","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjd.15939","article-title":"Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0022","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00403-020-02053-6","article-title":"Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients","volume":"312","author":"Riis","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0023","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.15770","article-title":"Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0024","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jdv.15822","article-title":"Hidradenitis suppurativa in patients with Down syndrome","volume":"33","author":"Veraldi","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000487799","article-title":"Hidradenitis suppurativa associated with Down syndrome is characterized by early age at diagnosis","volume":"234","author":"Giovanardi","year":"2018","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2340\/00015555-3095","article-title":"Prevalence and description of hidradenitis suppurativa in Down syndrome: A cross-sectional study of 783 subjects","volume":"99","author":"Poizeau","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0027","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaad.2020.08.045","article-title":"Hidradenitis suppurativa in pediatric patients","volume":"86","author":"Choi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0028","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clindermatol.2014.12.007","article-title":"Hidradenitis suppurativa in prepubescent and pubescent children","volume":"33","author":"Scheinfeld","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0029","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaad.2018.02.067","article-title":"Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents","volume":"79","author":"Tiri","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0030","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.3390\/ijerph18116131","article-title":"Quality of life in hidradenitis suppurativa: an update","volume":"18","author":"Chernyshov","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0031","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0032","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","article-title":"The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0034","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","article-title":"Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice?","volume":"94","author":"Matusiak","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1525-1470.2007.00544.x","article-title":"Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease","volume":"24","author":"Lam","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0036","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","article-title":"Hidradenitis suppurativa in children and adolescents: a review of treatment options","volume":"16","author":"Mikkelsen","year":"2014","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0037","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/09546634.2020.1716933","article-title":"Management of adolescents with hidradenitis suppurativa","volume":"32","author":"Collier","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0038","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000501611","article-title":"Undergarment and fabric selection in the management of hidradenitis suppurativa","volume":"237","author":"Loh","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0039","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1203475417745826","article-title":"The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa","volume":"22","author":"Alavi","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/adc.31.157.173","article-title":"Resorcin poisoning","volume":"31","author":"Cunningham","year":"1956","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0041","first-page":"S19","article-title":"Comparison of the adverse effect profile of different substances such as penicillins, tetracyclines, sulfonamides and quinolones","volume":"19","author":"Keller","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0042","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0009922806290026","article-title":"Absence of tooth staining with doxycycline treatment in young children","volume":"46","author":"Volovitz","year":"2007","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0043","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","article-title":"No visible dental staining in children treated with doxycycline for suspected rocky mountain spotted fever","volume":"166","author":"Todd","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0044","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/pde.13216","article-title":"Hidradenitis suppurativa in children treated with finasteride-a case series","volume":"34","author":"Mota","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1208\/s12248-019-0363-5","article-title":"Model-informed drug development approach supporting approval of adalimumab (HUMIRA) in adolescent patients with hidradenitis suppurativa: a regulatory perspective","volume":"21","author":"Bi","year":"2019","journal-title":"AAPS J"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0046","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/bjd.18029","article-title":"Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study","volume":"181","author":"Tha\u00e7i","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0047","first-page":"103","article-title":"Biologic treatment options for pediatric psoriasis and atopic dermatitis","volume":"6","author":"Cline","year":"2019","journal-title":"Children (Basel)"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0048","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2018.05.042","article-title":"Safety of adalimumab in pediatric patients with polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, psoriasis, and Crohn\u2019s disease","volume":"201","author":"Horneff","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0049","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/imt.15.114","article-title":"Adalimumab in pediatric Crohn\u2019s disease","volume":"8","author":"Patel","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/ced.13685","article-title":"Biologic therapy: a boon for hidradenitis suppurativa-like lesions complicating naevus comedonicus in a prepubertal child","volume":"44","author":"Sahu","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0051","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/12034754211049711","article-title":"Biologic use in pediatric patients with hidradenitis suppurativa: a systematic review","volume":"26","author":"Sachdeva","year":"2022","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0052","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/ced.12380","article-title":"Hidradenitis suppurativa treated with Clostridium botulinum toxin A","volume":"39","author":"Khoo","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.05.005_bib0053","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jdin.2021.11.007","article-title":"A visit guide for adolescent hidradenitis suppurativa: bridging the divide between pediatric and adult care","volume":"6","author":"Toledo","year":"2022","journal-title":"JAAD Int"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25001476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25001476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:40:25Z","timestamp":1753234825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X25001476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0738081X25001476"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.05.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis suppurativa in children and adolescents","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}